Department of Psychology, Hofstra University, Hempstead, New York, USA.
Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, California, USA.
Eur Eat Disord Rev. 2022 May;30(3):193-205. doi: 10.1002/erv.2887. Epub 2022 Feb 8.
Alexithymia is proposed as a prominent clinical feature of eating disorders (EDs). However, despite theoretical reason to believe that alexithymia could interfere with the success of treatments, few studies have tested whether alexithymia changes over the course of treatment. The goals of the current study were to evaluate (a) changes in alexithymia over the course of intensive Dialectical Behaviour Therapy (DBT) for EDs, and (b) associations between alexithymia and ED symptoms over time.
A mixed-diagnostic group of patients with EDs (N = 894) completed the Eating Disorders Examination-Questionnaire (EDE-Q) and the Toronto Alexithymia Scale (TAS-20) throughout intensive treatment and at various lengths of follow-up (6, 12, 24 months).
Results suggested that even after controlling for relevant covariates, there were significant decreases in alexithymia from intake to discharge and discharge to follow-up. Models exploring changes in self-reported ED symptoms indicated that TAS-20 scores significantly related to ED symptoms across timepoints, such that greater alexithymia was associated with greater severity of symptoms.
Altogether, findings support an association between alexithymia and ED symptoms over treatment and suggest that emotion-focussed therapies like DBT may result in decreases in alexithymia. Future research should explore whether this effect is consistent across therapies without an emotional focus.
述情障碍被认为是饮食失调(EDs)的一个突出临床特征。然而,尽管有理论上的理由认为述情障碍可能会干扰治疗的成功,但很少有研究测试述情障碍是否会在治疗过程中发生变化。本研究的目的是评估:(a)密集的辩证行为疗法(DBT)治疗 ED 过程中述情障碍的变化;(b)述情障碍与 ED 症状随时间的关联。
混合诊断组 ED 患者(N=894)在密集治疗期间和各种随访时间点(6、12、24 个月)完成饮食失调检查问卷(EDE-Q)和多伦多述情障碍量表(TAS-20)。
结果表明,即使在控制了相关协变量后,从入院到出院以及出院到随访,述情障碍仍显著下降。探索自我报告 ED 症状变化的模型表明,TAS-20 评分与各时间点的 ED 症状显著相关,即述情障碍越严重,症状越严重。
总的来说,这些发现支持述情障碍与治疗期间 ED 症状之间的关联,并表明像 DBT 这样以情绪为焦点的疗法可能会导致述情障碍的减少。未来的研究应探讨在没有情绪焦点的情况下,这种效应是否在各种疗法中一致。